Apogee Therapeutics, Inc. Logo

Apogee Therapeutics, Inc.

Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.

APGE | US

Overview

Corporate Details

ISIN(s):
US03770N1019
LEI:
Country:
United States of America
Address:
221 CRESCENT ST., 2453 WALTHAM
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Apogee Therapeutics, Inc. is a clinical-stage biotechnology company that develops therapies for immunological and inflammatory (I&I) diseases. The company's pipeline consists of novel antibody therapeutics and differentiated biologics designed to target established biological drivers. Apogee focuses on creating potentially best-in-class treatments for conditions with significant unmet needs, including dermatological, respiratory, and gastroenterological disorders like atopic dermatitis. Its scientific approach aims to develop medicines that offer improved efficacy and longer-lasting effects compared to the current standard of care, with the goal of improving the lives of patients with these chronic conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Apogee Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Apogee Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Apogee Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Zentiva 2 Logo
European provider of high-quality, affordable generic and over-the-counter medicines.
Slovakia
SKF
Zentiva S.A. Logo
Develops and distributes affordable generic, OTC, and specialty medicines across Europe.
Romania
SCD
ZERIA PHARMCEUTICAL CO., LTD. Logo
Develops and distributes prescription & consumer healthcare products in Europe and Asia.
Japan
4559
ZEVRA THERAPEUTICS, INC. Logo
A commercial-stage biopharma developing and delivering therapies for rare diseases.
United States of America
ZVRA
Zhengye Biotechnology Holding Ltd Logo
Researches, makes, and sells veterinary vaccines for China's livestock industry, focusing on swine.
United States of America
ZYBT
Zoetis Inc. Logo
Develops medicines, vaccines, and diagnostics for the health of livestock and companion animals.
United States of America
ZTS
Zura Bio Ltd Logo
Developing novel dual-pathway therapies for severe autoimmune and inflammatory conditions.
United States of America
ZURA
Zymeworks Inc. Logo
Develops multifunctional biotherapeutics to treat cancer and other serious diseases.
United States of America
ZYME
株式会社PRISM BioLab Logo
A biotech creating novel drugs by targeting previously "undruggable" protein interactions.
Japan
206A

Talk to a Data Expert

Have a question? We'll get back to you promptly.